30/01/2012
Report no. 16/2012
Amendment of a significant contract in the subsidiary company “Mikulicz” sp. z o.o. in Świebodzice
Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A., in connection with receiving as of 30 January 2012 contracts concluded with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) signed by the subsidiary company “Mikulicz” sp. z o.o. ) regarding healthcare services in the scope of outpatient specialist care and outpatient specialist care (cost-consuming outpatient diagnostic services), palliative and hospice care, psychiatric care and addiction treatment as well as rendering primary health care services for the period from 1 January to 31 December 2012
Healthcare services referred to hereinabove are provided by the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned by EMC Instytut Medyczny SA.
The Issuer informed about the contracts concluded by Mikulicz sp. z o.o. with the Fund Branch concerning rendering services in 2012 in its current report no 5/2012 of 20.01.2012.
As a result of signing the said contracts, the total maximum Fund Branch liability towards Mikulicz sp. z o.o. in Świebodzice has changed and it currently amounts to PLN 13,034,875.50 (an increase by PLN. 1,903,629.90) for the period from 1 January to 31 December 2012.
A criterion for a contract to be considered significant: The value of contracts exceeds 10% of the Issuer’s equity capital.